You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Somerset Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for SOMERSET, and what generic and branded alternatives to SOMERSET drugs are available?

SOMERSET has sixty-four approved drugs.

Summary for Somerset

US Patents:	0
Tradenames:	53
Ingredients:	51
NDAs:	64

Drugs and US Patents for Somerset

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Somerset	ATROPINE SULFATE	atropine sulfate	SOLUTION/DROPS;OPHTHALMIC	217791-001	Apr 29, 2024	AT2	RX	No	No		⤷ Sign Up				⤷ Sign Up
Somerset Theraps Llc	POTASSIUM PHOSPHATES	potassium phosphate, dibasic; potassium phosphate, monobasic	SOLUTION;INTRAVENOUS	217726-001	Jul 11, 2024	AP	RX	No	No		⤷ Sign Up				⤷ Sign Up
Somerset Theraps Llc	NALOXONE HYDROCHLORIDE	naloxone hydrochloride	INJECTABLE;INJECTION	207633-001	Aug 8, 2017	AP	RX	No	No		⤷ Sign Up				⤷ Sign Up
Somerset Theraps Llc	DOXYCYCLINE	doxycycline	TABLET;ORAL	065377-001	Nov 7, 2006		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Somerset Theraps Llc	NALBUPHINE HYDROCHLORIDE	nalbuphine hydrochloride	INJECTABLE;INJECTION	216050-002	Sep 19, 2024	AP	RX	No	No		⤷ Sign Up				⤷ Sign Up
Somerset Theraps Llc	BIMATOPROST	bimatoprost	SOLUTION/DROPS;OPHTHALMIC	207601-001	Jun 19, 2019	AT	RX	No	No		⤷ Sign Up				⤷ Sign Up
Somerset	SULFAMETHOXAZOLE AND TRIMETHOPRIM	sulfamethoxazole; trimethoprim	INJECTABLE;INJECTION	212231-001	Jun 26, 2019	AP	RX	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Somerset

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Somerset	EMSAM	selegiline	FILM, EXTENDED RELEASE;TRANSDERMAL	021336-003	Feb 27, 2006	RE34579	⤷ Sign Up
Somerset	EMSAM	selegiline	FILM, EXTENDED RELEASE;TRANSDERMAL	021336-001	Feb 27, 2006	7,070,808	⤷ Sign Up
Somerset	EMSAM	selegiline	FILM, EXTENDED RELEASE;TRANSDERMAL	021336-001	Feb 27, 2006	RE34579	⤷ Sign Up
Somerset	EMSAM	selegiline	FILM, EXTENDED RELEASE;TRANSDERMAL	021336-002	Feb 27, 2006	7,070,808	⤷ Sign Up
Somerset	EMSAM	selegiline	FILM, EXTENDED RELEASE;TRANSDERMAL	021336-002	Feb 27, 2006	RE34579	⤷ Sign Up
Somerset	EMSAM	selegiline	FILM, EXTENDED RELEASE;TRANSDERMAL	021336-002	Feb 27, 2006	7,638,140	⤷ Sign Up
Somerset	EMSAM	selegiline	FILM, EXTENDED RELEASE;TRANSDERMAL	021336-003	Feb 27, 2006	7,070,808	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.